Matches in Wikidata for { <http://www.wikidata.org/entity/Q91480592> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q91480592 description "article scientifique publié en 2019" @default.
- Q91480592 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q91480592 description "im Februar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91480592 description "scientific article published on 27 February 2019" @default.
- Q91480592 description "wetenschappelijk artikel" @default.
- Q91480592 description "наукова стаття, опублікована в лютому 2019" @default.
- Q91480592 name "Infliximab improved the refractory cutaneous involvement in a patient with dermatomyositis" @default.
- Q91480592 name "Infliximab improved the refractory cutaneous involvement in a patient with dermatomyositis" @default.
- Q91480592 type Item @default.
- Q91480592 label "Infliximab improved the refractory cutaneous involvement in a patient with dermatomyositis" @default.
- Q91480592 label "Infliximab improved the refractory cutaneous involvement in a patient with dermatomyositis" @default.
- Q91480592 prefLabel "Infliximab improved the refractory cutaneous involvement in a patient with dermatomyositis" @default.
- Q91480592 prefLabel "Infliximab improved the refractory cutaneous involvement in a patient with dermatomyositis" @default.
- Q91480592 P1433 Q91480592-2B8FEB70-32C6-4AEA-AA3F-1BC39DF4AB0A @default.
- Q91480592 P1476 Q91480592-3607440E-15C6-4B86-A00E-2DC305C03F0A @default.
- Q91480592 P2093 Q91480592-38F37991-A860-4A23-8881-24A50BEED9A9 @default.
- Q91480592 P2093 Q91480592-8A49C7ED-C2AA-4F14-B9FB-67A39D4A415A @default.
- Q91480592 P2093 Q91480592-BD44F75E-97AB-4172-A508-054F22C0DA14 @default.
- Q91480592 P2093 Q91480592-CB3CA22D-8FA0-4A49-9C46-0D12A859C484 @default.
- Q91480592 P304 Q91480592-57324FD1-FCA6-4929-BD35-069319D97080 @default.
- Q91480592 P31 Q91480592-0A555FF6-55D1-46C3-B61A-4A66884CDFF7 @default.
- Q91480592 P356 Q91480592-67A497DF-7153-494F-B935-DBEA1356F500 @default.
- Q91480592 P433 Q91480592-47ED3B25-F4CA-4AD4-8B67-D7DDFC3FE4DE @default.
- Q91480592 P478 Q91480592-760517F7-FA5C-4795-8F5E-3CE33BF2428A @default.
- Q91480592 P50 Q91480592-39A52558-AF12-458C-B641-CCF435F378B1 @default.
- Q91480592 P577 Q91480592-FE961E0C-6C4B-4B9F-925E-5D05CC899D93 @default.
- Q91480592 P698 Q91480592-5FC1C393-4139-4EE4-980B-675ACA9DDDC2 @default.
- Q91480592 P921 Q91480592-836F8C4F-B69D-44AB-B12A-354882C463DB @default.
- Q91480592 P356 DTH.12859 @default.
- Q91480592 P698 30748085 @default.
- Q91480592 P1433 Q15766374 @default.
- Q91480592 P1476 "Infliximab improved the refractory cutaneous involvement in a patient with dermatomyositis" @default.
- Q91480592 P2093 "Atsuko Kobayashi" @default.
- Q91480592 P2093 "Chinatsu Watanabe" @default.
- Q91480592 P2093 "Hironobu Ihn" @default.
- Q91480592 P2093 "Ikko Kajihara" @default.
- Q91480592 P304 "e12859" @default.
- Q91480592 P31 Q13442814 @default.
- Q91480592 P356 "10.1111/DTH.12859" @default.
- Q91480592 P433 "3" @default.
- Q91480592 P478 "32" @default.
- Q91480592 P50 Q91480588 @default.
- Q91480592 P577 "2019-02-27T00:00:00Z" @default.
- Q91480592 P698 "30748085" @default.
- Q91480592 P921 Q681160 @default.